Immunological profile of an infant treated with integrase inhibitor from the neonatal period
J Virus Erad
.
2019 Jan 1;5(1):47-49.
doi: 10.1016/S2055-6640(20)30279-X.
Authors
Lucia Taramasso
1
2
,
Chiara Dentone
3
,
Paola Tatarelli
1
,
Bianca Bruzzone
4
,
Francesco Marras
5
,
Andrea De Maria
5
,
Cristina Gotta
6
,
Elio Castagnola
7
,
Gilberto Filaci
8
,
Claudio Viscoli
1
9
,
Daniela Fenoglio
8
,
Antonio Di Biagio
9
Affiliations
1
University of Genoa, Department of Health Sciences (DISSAL), Genoa, Italy.
2
Infectious Diseases Unit, Department of Internal Medicine, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.
3
Infectious Diseases Department, Sanremo Hospital, Sanremo, Italy.
4
Hygiene Unit, Policlinico San Martino Hospital, Genoa, Italy.
5
Molecular Immunology, University of Genoa, Genoa, Italy.
6
Department of Obstetrics and Gynecology, Policlinico San Martino Hospital, Genoa, Italy.
7
Infectious Diseases Unit, Istituto Giannina Gaslini, Genoa, Italy.
8
Center of Excellence for Biomedical Research, University of Genoa, Genoa, Italy.
9
Infectious Diseases Unit, Policlinico San Martino Hospital, Genoa, Italy.
PMID:
30800427
PMCID:
PMC6362908
DOI:
10.1016/S2055-6640(20)30279-X
No abstract available
Publication types
Editorial